The TGFβ pathway is a potential avenue for cancer therapeutics due to its vital role in homoeostasis, induction of inflammatory cytokines in the ECM and regulation of T and B lymphocytes (Bellomo et al., 2016). Here, TGFB1 is linked to cancer.